Dan O’Connor

Executive Vice President - Commercial Translational Oncology Champions Oncology, Inc.

Seminars

Tuesday 20th October 2026
Shaping the Future of Early Access in Europe Understanding the Impact of New EU Pharmaceutical Legislation
8:30 am
  • Exploring what the new EU pharmaceutical legislation introduces for early and compassionate access pathways
  • Understanding the opportunities and challenges this creates for industry regulators and patients across Europe
  • Highlighting how stakeholders can collaborate to maximise the impact of the new framework
  • Setting the foundation for broader discussion on how early access can evolve under this changing regulatory landscape 
Dan O'Connor